Background: Antibacterial activity of local anesthetics especially lidocaine has been shown previously. In this study, the antibacterial effect of ketamine, a general anesthetic agent was investigated.
Methods: The antibacterial effect of ketamine was studied using six different strains of bacteria (Staphylococcus aureus, Staphylococcus epidermidis, Entecoccus faecalis, Streptococcus pyogenes, Pseudomonas aeruginosa and Escherichia coli) with disc diffusion method. Ciprofloxacine discs (CIP, oxoid) were used as a control to verify the methodology. Minimal inhibition concentration (MIC) and minimal bactericidal concentration (MBC) of ketamine for these bacteria were also determined.
Results: No inhibition was evident in discs containing 62.5 microg of ketamine. Ketamine 125 microg showed activity on all the bacteria tested with the exception of E. coli. The inhibition rates of Ketamine were more prominent at the doses of 250 microg and 500 microg similar to the inhibition rate of CIP. Whereas MIC and MBC values of ketamine for S. aureus and S. pyogenes were 500 microg mL(-1), MIC and MBC values for P. aeruginosa were above 2000 microg mL(-1). For other bacteria, these values ranged between these levels.
Conclusions: Ketamine with higher doses showed antibacterial activity. We thought that it will be proper to use ketamine hesitantly in experimental animal studies like sepsis and translocation.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.3109/2000-1967-211 | DOI Listing |
J Med Chem
November 2024
Neuroscience Drug Discovery Denmark, H. Lundbeck A/S, 9 Ottiliavej, Valby, DK-2500 Copenhagen, Denmark.
The discovery of d-cycloserine (), a partial agonist of the NMDA receptor that exhibits antidepressant effects without the psychotomimetic effects of ketamine, has fueled interest in new NMDA-targeting antidepressants. Our objective was to identify potent partial agonists mirroring , particularly tailored for the GluN2B subtype of the NMDA receptor. Through a structure-based drug design approach, we discovered compound .
View Article and Find Full Text PDFAm J Transl Res
October 2024
Department of Chemistry, College of Science, United Arab Emirates University Al-Ain 15551, UAE.
Aging (Albany NY)
July 2024
Woodinville Psychiatric Associates, Woodinville, WA 98072, USA.
Background: Gain of function disturbances in nutrient sensing are likely the largest component in human age-related disease. Mammalian target of rapamycin complex 1 (mTORC1) activity affects health span and longevity. The drugs ketamine and rapamycin are effective against chronic pain and depression, and both affect mTORC1 activity.
View Article and Find Full Text PDFDrug Des Devel Ther
March 2024
Clinical and Health Sciences, University of South Australia, Adelaide, SA, Australia.
Purpose: Co-administering multiple intravenous (IV) agents via Y-connectors is a common practice in hospitalised and fasting surgical patients. However, there is a lack of reliable data confirming the physical compatibility of some combinations including IV oxycodone, a drug that is gaining increasing popularity in the perioperative period. Concern regarding physical drug incompatibilities precludes concurrent coadministration with other common drugs through a single lumen.
View Article and Find Full Text PDFEur J Obstet Gynecol Reprod Biol
March 2024
Université Paris-Cité, AP-HP, Hôpital Bichat, Service d'urologie, Paris F-75017, France.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!